A detailed history of Scout Investments, Inc. transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Scout Investments, Inc. holds 203,501 shares of NBIX stock, worth $25.1 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
203,501
Previous 189,870 7.18%
Holding current value
$25.1 Million
Previous $26.1 Million 10.37%
% of portfolio
0.69%
Previous 0.76%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$114.58 - $153.15 $1.56 Million - $2.09 Million
13,631 Added 7.18%
203,501 $23.4 Million
Q2 2024

Aug 12, 2024

BUY
$130.86 - $143.19 $10.9 Million - $11.9 Million
83,345 Added 78.24%
189,870 $26.1 Million
Q1 2024

May 09, 2024

SELL
$130.4 - $143.74 $20.2 Million - $22.3 Million
-155,093 Reduced 59.28%
106,525 $14.7 Million
Q4 2023

Feb 13, 2024

SELL
$106.07 - $132.76 $11.1 Million - $13.8 Million
-104,199 Reduced 28.48%
261,618 $34.5 Million
Q3 2023

Nov 09, 2023

BUY
$94.02 - $117.1 $1.3 Million - $1.62 Million
13,870 Added 3.94%
365,817 $41.2 Million
Q2 2023

Aug 14, 2023

BUY
$89.53 - $104.87 $19.8 Million - $23.2 Million
221,618 Added 170.05%
351,947 $33.2 Million
Q1 2023

May 11, 2023

SELL
$94.11 - $123.02 $2.71 Million - $3.54 Million
-28,810 Reduced 18.1%
130,329 $13.2 Million
Q4 2022

Jan 23, 2023

SELL
$106.72 - $127.06 $7.87 Million - $9.38 Million
-73,785 Reduced 31.68%
159,139 $0
Q3 2022

Oct 18, 2022

SELL
$92.03 - $107.81 $800,384 - $937,623
-8,697 Reduced 3.6%
232,924 $24.7 Million
Q1 2022

Apr 14, 2022

SELL
$72.45 - $94.81 $545,838 - $714,298
-7,534 Reduced 3.02%
241,621 $22.7 Million
Q4 2021

Jan 14, 2022

SELL
$79.65 - $106.22 $442,774 - $590,476
-5,559 Reduced 2.18%
249,155 $21.2 Million
Q3 2021

Oct 13, 2021

SELL
$86.18 - $99.03 $336,446 - $386,613
-3,904 Reduced 1.51%
254,714 $24.4 Million
Q2 2021

Jul 23, 2021

BUY
$89.43 - $102.27 $5.03 Million - $5.75 Million
56,228 Added 27.78%
258,618 $25.2 Million
Q1 2021

Apr 09, 2021

SELL
$87.57 - $119.4 $2.67 Million - $3.64 Million
-30,445 Reduced 13.08%
202,390 $19.7 Million
Q4 2020

Jan 12, 2021

SELL
$86.91 - $108.33 $169,039 - $210,701
-1,945 Reduced 0.83%
232,835 $22.3 Million
Q3 2020

Oct 13, 2020

BUY
$96.16 - $135.15 $5.87 Million - $8.25 Million
61,059 Added 35.15%
234,780 $22.6 Million
Q2 2020

Jul 14, 2020

BUY
$85.09 - $130.36 $14.8 Million - $22.6 Million
173,721 New
173,721 $21.2 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Scout Investments, Inc. Portfolio

Follow Scout Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scout Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scout Investments, Inc. with notifications on news.